Evidence map›Paper›PMID 42432350›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Evaluation of modafinil's neuroprotective effects in lipopolysaccharide-induced sepsis-associated encephalopathy: associations with GSK3β, inflammatory, oxidative stress, and apoptotic signaling.

Mehtap Savran, Ahmet Yunus Hatip, Sanem Aşcı, Ali Serdar Oğuzoğlu, Emine Sarman, Muhammet Yusuf Tepebaşı, Ahmet Bindal, Abdurrahman Gülal, Halil Aşcı

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mehtap SavranDepartment of Medical Pharmacology, Faculty of Medicine, Suleyman Demirel University, Isparta, Türkiye.ORCID http://orcid.org/0000-0002-7933-0453
Ahmet Yunus HatipDepartment of Emergency Medicine, Faculty of Medicine, Suleyman Demirel University, Isparta, Türkiye. ahmethatip@sdu.edu.tr.ORCID https://orcid.org/0000-0002-7595-2175
Sanem AşcıDepartment of Neurology, Faculty of Medicine, Suleyman Demirel University, Isparta, Türkiye.ORCID http://orcid.org/0000-0002-1283-2096
Ali Serdar OğuzoğluDepartment of Neurosurgery, Faculty of Medicine, Suleyman Demirel University, Isparta, Türkiye.ORCID http://orcid.org/0000-0002-1735-4062
Emine SarmanDepartment of Histology and Embryology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, Türkiye.ORCID http://orcid.org/0000-0002-4671-9315
Muhammet Yusuf TepebaşıDepartment of Medical Genetics, Faculty of Medicine, Suleyman Demirel University, Isparta, Türkiye.ORCID http://orcid.org/0000-0002-1087-4874
Ahmet BindalDepartment of Anesthesiology and Reanimation, Faculty of Medicine, Suleyman Demirel University, Isparta, Türkiye.ORCID http://orcid.org/0000-0002-1971-6856
Abdurrahman GülalDepartment of Pharmacology, Institute of Health Sciences, Suleyman Demirel University, Isparta, Türkiye.ORCID http://orcid.org/0009-0007-1743-412X
Halil AşcıDepartment of Medical Pharmacology, Faculty of Medicine, Suleyman Demirel University, Isparta, Türkiye.ORCID http://orcid.org/0000-0002-1545-035X

Funding

Süleyman Demirel Üniversitesi Grant number: TSG-2024-9556
6 · The paper itself

Abstract

Sepsis is frequently accompanied by central nervous system involvement, leading to sepsis-associated encephalopathy characterized by neuroinflammation, microvascular dysfunction, and neuronal injury. Despite increasing recognition of its clinical impact, effective neuroprotective strategies remain limited. Modafinil (MOD), a wakefulness-promoting agent, has recently attracted attention for its anti-inflammatory, antioxidant, and neuroprotective properties in experimental models. Experimental sepsis was induced by intraperitoneal administration of lipopolysaccharide (LPS) in adult female Wistar rats. Animals were randomly assigned to four groups: control, LPS, LPS plus MOD, and MOD alone. Cerebral tissue was harvested six hours after LPS administration. Caspase-3 and tumor necrosis factor-alpha (TNF-α) expressions were assessed by immunohistochemistry. Oxidative stress was evaluated by measuring total oxidant status (TOS), total antioxidant status (TAS), and the oxidative stress index (OSI) in cerebral tissue homogenates. Gene expression levels of AKT1, glycogen synthase kinase 3 beta (GSK3B), sirtuin 1 (SIRT1), and heme oxygenase-1 (HO-1) were analyzed by quantitative PCR. LPS administration produced significant increases in Caspase-3 and TNF-α immunoreactivity in both cerebral cortex and cerebellum. At the oxidative stress level, LPS significantly elevated TOS and OSI while reducing TAS, indicating a pronounced shift toward pro-oxidant conditions. At the molecular level, LPS significantly increased GSK3B expression while reducing HO-1 expression. MOD treatment significantly reduced Caspase-3 and TNF-α immunoreactivity in both regions, restored the oxidative balance as evidenced by significantly attenuated TOS and OSI levels, and significantly suppressed GSK3B upregulation, whereas its effect on HO-1, AKT1, and SIRT1 expression did not reach statistical significance. MOD mitigates sepsis-induced cerebral and cerebellar injury by attenuating neuroinflammation, oxidative stress, and apoptosis. The accompanying decrease in GSK3B expression suggests that GSK3β-related signaling may contribute to these effects, although this relationship is associative rather than causal. MOD may therefore warrant further evaluation as a neuroprotective agent in sepsis-related CNS injury.

Indexed as

ApoptosisEncephalopathyLipopolysaccharidesModafinilOxidative stressSepsis

Identifiers

PMID42432350

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.